Kathleen Miller Margalit

Kathleen Miller Margalit is an experienced professional in commercial development and marketing within the pharmaceutical industry, currently serving as Senior Director of Commercial Development and Planning for cannabinoids at Jazz Pharmaceuticals since October 2021. Prior to this role, Kathleen held key positions at UCB, including Commercial Lead for Rozimab, where responsibilities encompassed global launch strategies and patient engagement initiatives, and earlier roles in strategic marketing for the epilepsy franchise. Additional experience includes leadership positions in product management at MiMedx and Vertex Pharmaceuticals, where Kathleen oversaw marketing strategies and training programs for various drug launches. Educational qualifications include an MBA from Northwestern University’s Kellogg School of Management, a Master’s in Pharmacology and Cancer Biology, and a Bachelor’s in Biology from Duke University.